Eli Lilly Introduces Affordable Zepbound Vials to Address Obesity Medication Shortages
Eli Lilly has launched a cost-effective alternative for its weight-loss medication, Zepbound, by offering single-dose vials at significantly reduced prices. This strategic move aims to address the overwhelming demand and enhance accessibility for patients struggling with obesity. The introduction of 2.5 mg and 5 mg tirzepatide vials at about half the cost of previous options […]